UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6

International journal of molecular sciences, 2024-05, Vol.25 (10), p.5355

2024

Volltextzugriff (PDF)

The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature

Pathology, 2024-08, Vol.56 (5), p.662-670

2024

Volltextzugriff (PDF)

Fibroblast Activation Protein-Directed Imaging Outperforms 18 F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Journal of Nuclear Medicine, 2024-08, Vol.65 (8), p.1188-1193

2024

Volltextzugriff (PDF)

Different Frequency and Clinical Role for MTAP Loss in Pleural and Peritoneal Mesothelioma

Applied immunohistochemistry & molecular morphology, 2024-07, Vol.32 (6), p.280-284

2024

Volltextzugriff (PDF)

Pleural mesothelioma from fluoro-edenite exposure: PACAP and PAC1 receptor. A preliminary report

European journal of histochemistry, 2024-05, Vol.68 (2)

2024

Volltextzugriff (PDF)

Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion

Biomolecules (Basel, Switzerland), 2021-10, Vol.11 (11), p.1606

2021

Volltextzugriff (PDF)

Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?

Biotechnic & histochemistry, 2020-04, Vol.95 (3), p.171-175

2020

Volltextzugriff (PDF)

Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma

Zhonghua laodong weisheng zhiyebing zazhi, 2024-04, Vol.42 (4), p.258

2024

Volltextzugriff (PDF)

The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma

Nuclear medicine communications, 2017-04, Vol.38 (4), p.312-318

2017

Volltextzugriff (PDF)

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

PloS one, 2015-03, Vol.10 (3), p.e0121071-e0121071

2015

Volltextzugriff (PDF)

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Human pathology, 2019-05, Vol.87, p.11-17

2019

Volltextzugriff (PDF)

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry

Lung cancer (Amsterdam, Netherlands), 2017-02, Vol.104, p.98-105

2017

Volltextzugriff (PDF)

A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis

Lung cancer (Amsterdam, Netherlands), 2018-11, Vol.125, p.198-204

2018

Volltextzugriff (PDF)

Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study

Journal of clinical oncology, 2019-04, Vol.37 (10), p.790-798

2019

Volltextzugriff (PDF)

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma

Human pathology, 2015-11, Vol.46 (11), p.1670-1678

2015

Volltextzugriff (PDF)

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma

Modern pathology, 2016-01, Vol.29 (1), p.14-24

2016

Volltextzugriff (PDF)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

Thorax, 2014-10, Vol.69 (10), p.895-902

2014

Volltextzugriff (PDF)

Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma

PloS one, 2014-09, Vol.9 (9), p.e106742-e106742

2014

Volltextzugriff (PDF)

Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study

Journal of thoracic oncology, 2015-03, Vol.10 (3), p.492-499

2015

Volltextzugriff (PDF)

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas

Journal of thoracic oncology, 2017-04, Vol.12 (4), p.724-733

2017

Volltextzugriff (PDF)

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma

Annals of oncology, 2015-12, Vol.26 (12), p.2483-2490

2015

Volltextzugriff (PDF)

High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma

International immunopharmacology, 2024-05, Vol.133, p.112039-112039, Article 112039

2024

Volltextzugriff (PDF)

Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study

Human pathology, 2018-02, Vol.72, p.160-166

2018

Volltextzugriff (PDF)

Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series

Pathology, research and practice, 2024-07, Vol.259, p.155350, Article 155350

2024

Volltextzugriff (PDF)

Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications

JNCI : Journal of the National Cancer Institute, 2018-10, Vol.110 (10), p.1102-1114

2018

Volltextzugriff (PDF)

1 – 25 von 741

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(688)
Mit Volltextzugriff
(649)

Publikationsform

Artikel
(740)
magazinearticle
(1)

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6

The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature

Fibroblast Activation Protein-Directed Imaging Outperforms 18 F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Different Frequency and Clinical Role for MTAP Loss in Pleural and Peritoneal Mesothelioma

Pleural mesothelioma from fluoro-edenite exposure: PACAP and PAC1 receptor. A preliminary report

Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion

Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?

Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma

The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry

A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis

Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma

Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma

High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma

Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study

Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series

Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications

Aktive Filter

Suchergebnisse filtern